Navigation Links
Statins Show Promise Against Sickle Cell
Date:1/19/2010

The cholesterol drugs might reduce risk of infection, researchers find

TUESDAY, Jan. 19 (HealthDay News) -- The cholesterol drugs known as statins hold promise as a treatment for sickle cell disease, a common genetic disorder, new research has found.

The findings, published Jan. 19 in the Journal of Clinical Investigation, are based on experiments with mice, so it's not clear if humans with the disease will benefit from treatment with statins.

Researchers at St. Jude Children's Research Hospital in Memphis, Tenn., found that among mice with a type of sickle cell disease, those that were treated with statins lived much longer after being infected with pneumococcal bacteria than those who didn't get the treatment.

The cholesterol drugs appeared to stop cells from being killed by bacterial toxins and reduced the risk that germs would invade the blood system, according to the report.

Children with sickle cell disease face a serious threat from pneumococcal bacteria, and the researchers think preventive treatment with statins may reduce their risk of infection.

More information

The Nemours Foundation has more on sickle cell disease.



-- Randy Dotinga



SOURCE: Journal of Clinical Investigation, news release, Jan. 19, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. More Evidence That Statins Cut Stroke Risk
2. American Heart Association Late Breaking Clinical Trial Report: In Patients on Statins, Raising Good Cholesterol with Niacin, but not Reducing Bad Cholesterol with Ezetimibe, Decreases Plaque Build-Up
3. Statins May Stave Off Gallstones
4. Statins May Worsen Fatigue in Heart Failure Patients
5. Use of statins favors the wealthy, creating new social disparities in cholesterol
6. Study Suggests a Wider Use for Statins
7. Statins Before Vascular Surgery Cut Deaths, Complications
8. Giving Statins to Kids Provokes Debate
9. Blood vessel bends and branches put the brakes on statins
10. British Medical Journal Report Supports SCHS White Paper on Statins
11. Statins May Cause Muscle Damage in Some Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... February 06, 2016 , ... ... PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , ... with an estimated 5000 perioperative nurses in attendance to study the latest ...
(Date:2/6/2016)... ... 2016 , ... With the FCPX LUT: Summer pack from Pixel ... A LUT is a Lookup Table that contains a mathematical formula for modifying an ... table. By manipulating each pixel, LUT's can change each color range differently, it gives ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research has shown that ... reduce the frequency and level of relapse. , At the 2016 ... Purpose,” will explore the critical tasks of the recovery phase and beyond including ...
(Date:2/5/2016)... ... 05, 2016 , ... Love is in the air at King Kullen! The ... and packaging. This staple for Valentine’s Day is a must-have, and can be picked ... Day, not only are long-stem roses available, but also other flower bouquets, elegantly wrapped ...
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV ... the much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream ... Each week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016 Aethlon Medical, Inc. ... , Chairman and CEO, will be presenting at Source Capital ... New York, NY at 2:15 p.m. ET on ... an Immunotherapy Panel discussion taking place at 3:15 p.m. ET. ... replay approximately one hour after the conclusion of the live ...
(Date:2/5/2016)... 5, 2016 --> ... states that the global active pharmaceuticals ingredients (APIs) market ... to reach US$185.9 bn by 2020. It is expected ... to 2020. The title of the report is "Active ... Geography, and by Therapeutic Area) - Global Industry Analysis, ...
(Date:2/5/2016)... WARSAW, Ind. , Feb. 5, 2016  Zimmer ... the pricing of the previously announced underwritten secondary offering ... of its stockholders, consisting of affiliates of Blackstone and ... public at an initial price of $96.45 per share. ... of the offering.  Neither Zimmer Biomet nor any of ...
Breaking Medicine Technology: